Cash & equivalents increased 121.3%
Cash & equivalents changed +121.3% from the comparable as-filed period.
$229.4M→$507.7M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →GMED financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income decreased 25.3%
Net income changed -25.3% from the comparable as-filed period.
$202.8M→$151.6M3 prior comparisons
Operating income increased 139.7%
Operating income changed +139.7% from the comparable as-filed period.
$76.1M→$182.4M3 prior comparisons
Operating margin moved 1289 bp higher
Operating margin changed +1289 basis points from the comparable as-filed period.
10.21%→23.10%3 prior comparisons
Inventory increased 5.0%
Inventory changed +5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$772.1M→$810.9M4 prior comparisons
Research & development decreased 9.1%
Research & development changed -9.1% from the comparable as-filed period.
$40.0M→$36.3M3 prior comparisons
Revenue increased 5.9%
Revenue changed +5.9% from the comparable as-filed period.
$745.3M→$789.6M3 prior comparisons
Selling, general & administrative decreased 5.5%
Selling, general & administrative changed -5.5% from the comparable as-filed period.
$303.6M→$286.8M3 prior comparisons
Stock-based compensation decreased 1.7%
Stock-based compensation changed -1.7% from the comparable as-filed period.
$13.6M→$13.4M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.